Small team, Global impact With a lean team of 2-10 employees and international service delivery, there is a clear need for scalable, partner-friendly solutions that can augment workstreams without adding headcount. This presents an opportunity to position Qmetrics with adaptable software, white-label options, or managed services to extend their capabilities globally.

FDA Cleared Differentiator Kuvia3D is FDA cleared for 3D visualization of joint anatomy, which can be leveraged to differentiate in the surgical planning and therapeutic decision support space. A sales approach could target orthopedic surgeons, radiology groups, and medical device companies seeking compliant, proven imaging analytics to improve planning and outcomes.

AI Driven Biomarkers Their AI and deep learning capabilities for extracting biomarkers and tracking disease progression open avenues to offer data infrastructure, data partnerships, or integration services that enhance clinical trials, post-market studies, and accelerated therapy efficacy assessments for biotech and pharma clients.

Clinical Trial Enablement Automated, quantifiable imaging analytics can improve trial endpoint accuracy and efficiency. This suggests upsell opportunities around trial design analytics, imaging protocol standardization, and centralized image analysis services for CROs and sponsors looking to reduce variability and cost.

Strategic Partnerships Co-founders with a global reach combined with a concise product line indicate potential for channel partnerships with larger imaging software ecosystems, hospitals, and academic centers. A partnership strategy could focus on integrations, referral networks, and joint go-to-market campaigns to expand adoption.